FDA Speaker Confirmed
We are happy to announce that Dr. Jeffrey Baker, Deputy Director, OBP, CDER, FDA is now confirmed to speak at TIDES 2014. Dr. Baker's presentation will discuss the preparations needed for companies that are seeking rapid drug approval as part of the FDA Safety and Innovation Act.
2014 Keynote Speakers Provide Innovative Science and Updates to Prepare You for the Future:
Peptide R&D: Advances and Opportunities
Nader Fotouhi, Ph.D., Vice President, Head of Discovery Technologies, Hoffmann-La Roche
Pharmaceutical Protein and Peptide Engineering
Lars F. Iversen, Ph.D., Corporate Vice President, Diabetes Protein Engineering, Novo Nordisk, Denmark
Aptamer Nanotechnology for Therapeutic Nanoparticles
Omid Farokhzad, M.D., Associate Professor; Director, Laboratory of Nanomedicine and Biomaterials, Brigham and Women's Hospital, Harvard Medical School
Peptide-Based Vaccines in the New Era of Cancer Immunotherapy
Eric von Hofe, Ph.D., President, Antigen Express, Inc.
PeptiDream: From Bench to IPO
Patrick C. Reid, Ph.D., Chief Scientific Officer, PeptiDream Inc., Japan and U.S.A.
Also available: Complimentary Keynote Presentations from TIDES 2013 To give you a sneak peek of the high quality content available at TIDES, we are providing access to a few of our keynote presentations from last year's TIDES conference - Bruce Booth, Jim Heath, Mary McGowan.
To learn more, download our agenda.
Register with code XB14180BLOG by Friday (1/17) and save 20% off the standard rate. If you have questions about the event, feel free to contact our group manager, Kate Devery (Kdevery@iirusa.com), or visit our webpage. We look forward to seeing you May 12-15 in Providence, RI!
Cheers,
The Oligo & Peptide Team
Opt-in for updates
Follow us on Twitter
TIDES LinkedIn
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment